Review summary
Teaching objective: Long-term care of a man with young-onset Parkinson's disease twelve years after diagnosis: a structured motor examination and Hoehn and Yahr stage at every visit; levodopa dose and timing adjusted for bradykinesia with supine and standing blood pressure checks; screening for falls, swallowing problems, mood, cognition, sleep, autonomic symptoms, psychosis, and impulse control; speech therapy for soft speech and physical therapy for gait and balance; avoidance of dopamine-blocking drugs; and advance care planning, on the CMID Parkinson's disease schedule with AAN and MDS guidance. The publicly discussed link to boxing is treated as a disputed retrospective interpretation, not a diagnosis.
Historical timeline
| Date | Event | Claims |
|---|---|---|
| January 17, 1942 | Born Cassius Clay in Louisville, Kentucky. | CLM-0001 |
| 1981 | Retired from professional boxing. | CLM-0003 |
| 1984 | Diagnosed at 42 with a parkinsonian condition by a neurologist in New York. | CLM-0003, CLM-0004 |
| 1996 | His physician described the condition in a television interview and said his cognitive function had not declined. | CLM-0005 |
| July 19, 1996 | Lit the Olympic cauldron in Atlanta; his hand shook as he held the torch. | CLM-0007 |
| 1997 | Co-founded the Muhammad Ali Parkinson Center in Phoenix. | CLM-0008 |
| June 3, 2016 | Died in the Phoenix area at 74. | CLM-0002 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | Muhammad Ali was born Cassius Clay in Louisville, Kentucky, on January 17, 1942. | confirmed | Muhammad Ali: Explore the Life and Legacy of The Greatest supports |
| D | Ali died on June 3, 2016, in the Phoenix area, at age 74. A family spokesman gave the cause as septic shock due to unspecified natural causes. Record the death as a fact without detail. |
confirmed | Muhammad Ali: Explore the Life and Legacy of The Greatest supports Muhammad Ali Dies at 74 supports Death of Muhammad Ali: Boxer died of septic shock supports |
| D | In 1984, at age 42 and three years after he retired from boxing, Ali was diagnosed with a parkinsonian condition by the neurologist Stanley Fahn in New York; it has been publicly described as Parkinson's disease since. The anchor for the synthetic Parkinson's disease. Sources label it parkinsonism, Parkinson's syndrome, or Parkinson's disease. |
confirmed | Doctor who diagnosed Muhammad Ali with Parkinson's speaks out supports Muhammad Ali's long struggle with Parkinson's disease supports Muhammad Ali Had 'a Mission' to Fight Parkinson's Disease supports Ali doctor: 'Muhammad had no regrets about boxing' supports |
| D | The diagnosing neurologist later said publicly that slowness of movement was Ali's main limitation at the time of diagnosis, with a masked face, decreased blinking, a typical parkinsonian tremor, and a shuffling gait, and that some features were too early for classic Parkinson's disease. Physician's public account, given after Ali's death. |
confirmed | Doctor who diagnosed Muhammad Ali with Parkinson's speaks out supports |
| D | In a 1996 television interview, Ali's physician Dennis Cope described his condition as Parkinson's syndrome attributed to pugilistic brain syndrome from boxing, and said testing showed his cognitive function had not declined: "His mind is fine." Physician's public statement; it supports the synthetic normal cognitive screen. |
confirmed | Muhammad Ali's long struggle with Parkinson's disease supports |
| R | Whether boxing caused Ali's Parkinson's disease is disputed. The diagnosing neurologist thought the early symptoms were probably caused by repeated blows to the head but could not be certain; his later physician Abraham Lieberman did not think boxing contributed, though he was not a hundred percent certain; and the director of the Muhammad Ali Parkinson Center said there was no medical evidence that boxing contributed. Retrospective causal interpretation; not coded as a diagnosis. |
disputed | Doctor who diagnosed Muhammad Ali with Parkinson's speaks out supports Ali doctor: 'Muhammad had no regrets about boxing' disputes Muhammad Ali Had 'a Mission' to Fight Parkinson's Disease disputes |
| D | As the disease progressed, Ali developed a tremor and his speech became increasingly difficult. When he lit the Olympic cauldron in Atlanta on July 19, 1996, his hand shook as he held the torch. The anchor for the tremor and the synthetic soft speech; the cauldron lighting fixes the index year. |
confirmed | Muhammad Ali's long struggle with Parkinson's disease supports Muhammad Ali Dies at 74 supports |
| D | Ali, his physician Abraham Lieberman, and a Phoenix philanthropist founded the Muhammad Ali Parkinson Center at the Barrow Neurological Institute in 1997. Lieberman, who was among those who diagnosed him in 1984 and later treated him, said Ali stood up to the disease for 34 years and that in his final years he lost the ability to speak and use his hands. Physician's public statements after Ali's death; the late-stage details postdate the episode and are not used in it. |
confirmed | Muhammad Ali Had 'a Mission' to Fight Parkinson's Disease supports Ali doctor: 'Muhammad had no regrets about boxing' supports |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | Parkinson's disease, young onset (diagnosed at 42), Hoehn and Yahr stage 2.5, without dyskinesia or motor fluctuations | active | confirmed | both_with_link | CLM-0003, CLM-0004, CLM-0005 |
| S | Hypokinetic dysarthria with soft speech due to Parkinson's disease | active | confirmed | active | CLM-0007 |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 1996-02-10 | Hemoglobin [Mass/volume] in Blood | 14.6 g/dL Reference 13.2-16.6 g/dL |
http://loinc.org · 718-7 |
| S | 1996-02-10 | Sodium [Moles/volume] in Serum or Plasma | 140 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1996-02-10 | Potassium [Moles/volume] in Serum or Plasma | 4.3 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1996-02-10 | Creatinine [Mass/volume] in Serum or Plasma | 1.02 mg/dL Reference 0.74-1.35 mg/dL |
http://loinc.org · 2160-0 |
| S | 1996-02-10 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1991)/1.73 sq M | 87 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 1996-02-10 | Glucose [Mass/volume] in Serum or Plasma | 92 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 1996-02-10 | Calcium [Mass/volume] in Serum or Plasma | 9.5 mg/dL Reference 8.6-10.3 mg/dL |
http://loinc.org · 17861-6 |
| S | 1996-02-10 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 512 pg/mL Reference 232-1245 pg/mL |
http://loinc.org · 2132-9 |
| S | 1996-02-10 | Thyrotropin [Units/volume] in Serum or Plasma | 1.8 mIU/L Reference 0.45-4.5 mIU/L |
http://loinc.org · 3016-3 |
| S | 1996-02-10 | Total score [MoCA] | 27 | http://loinc.org · 72172-0 |
| S | 1996-02-10 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | http://loinc.org · 44261-6 |
| S | 1996-10-06 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | http://loinc.org · 55758-7 |
| S | 1996-10-06 | Total score [AUDIT-C] | 0 | http://loinc.org · 75626-2 |
| S | 1996-10-06 | Cholesterol [Mass/volume] in Serum or Plasma | 192 mg/dL Reference <=200 mg/dL |
http://loinc.org · 2093-3 |
| S | 1996-10-06 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 50 mg/dL Reference >=40 mg/dL |
http://loinc.org · 2085-9 |
| S | 1996-10-06 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 118 mg/dL Reference <=129 mg/dL |
http://loinc.org · 13457-7 |
| S | 1996-10-06 | Triglyceride [Mass/volume] in Serum or Plasma | 120 mg/dL Reference <=149 mg/dL |
http://loinc.org · 2571-8 |
| S | 1996-10-06 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.4% Reference <=5.6% |
http://loinc.org · 4548-4 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 1996-02-10 | Body height | 191 cm | 8302-2 | S |
| 1996-02-10 | Body weight | 102 kg | 29463-7 | S |
| 1996-02-10 | Body mass index (BMI) [Ratio] | 28 kg/m2 | 39156-5 | S |
| 1996-02-10 | Systolic blood pressure | 128 mm[Hg] | 8480-6 | S |
| 1996-02-10 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 1996-02-10 | Heart rate | 72 /min | 8867-4 | S |
| 1996-02-10 | Respiratory rate | 14 /min | 9279-1 | S |
| 1996-02-10 | Body temperature | 36.7 Cel | 8310-5 | S |
| 1996-02-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1996-03-10 | Body height | 191 cm | 8302-2 | S |
| 1996-03-10 | Body weight | 102 kg | 29463-7 | S |
| 1996-03-10 | Body mass index (BMI) [Ratio] | 28 kg/m2 | 39156-5 | S |
| 1996-03-10 | Systolic blood pressure | 126 mm[Hg] | 8480-6 | S |
| 1996-03-10 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 1996-03-10 | Heart rate | 70 /min | 8867-4 | S |
| 1996-03-10 | Respiratory rate | 14 /min | 9279-1 | S |
| 1996-03-10 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1996-03-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1996-06-09 | Body height | 191 cm | 8302-2 | S |
| 1996-06-09 | Body weight | 101.5 kg | 29463-7 | S |
| 1996-06-09 | Body mass index (BMI) [Ratio] | 27.8 kg/m2 | 39156-5 | S |
| 1996-06-09 | Systolic blood pressure | 124 mm[Hg] | 8480-6 | S |
| 1996-06-09 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 1996-06-09 | Heart rate | 72 /min | 8867-4 | S |
| 1996-06-09 | Respiratory rate | 14 /min | 9279-1 | S |
| 1996-06-09 | Body temperature | 36.7 Cel | 8310-5 | S |
| 1996-06-09 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1996-09-08 | Body height | 191 cm | 8302-2 | S |
| 1996-09-08 | Body weight | 101 kg | 29463-7 | S |
| 1996-09-08 | Body mass index (BMI) [Ratio] | 27.7 kg/m2 | 39156-5 | S |
| 1996-09-08 | Systolic blood pressure | 126 mm[Hg] | 8480-6 | S |
| 1996-09-08 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 1996-09-08 | Heart rate | 70 /min | 8867-4 | S |
| 1996-09-08 | Respiratory rate | 14 /min | 9279-1 | S |
| 1996-09-08 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1996-09-08 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1996-10-06 | Body height | 191 cm | 8302-2 | S |
| 1996-10-06 | Body weight | 101.2 kg | 29463-7 | S |
| 1996-10-06 | Body mass index (BMI) [Ratio] | 27.7 kg/m2 | 39156-5 | S |
| 1996-10-06 | Systolic blood pressure | 124 mm[Hg] | 8480-6 | S |
| 1996-10-06 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 1996-10-06 | Heart rate | 70 /min | 8867-4 | S |
| 1996-10-06 | Respiratory rate | 14 /min | 9279-1 | S |
| 1996-10-06 | Body temperature | 36.7 Cel | 8310-5 | S |
| 1996-10-06 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S No tobacco use; no alcohol (AUDIT-C 0 at the preventive visit); no other drug use
- S Retired professional boxer; married and lives with his spouse; travels often for public and charitable appearances
- S Walks for 30 minutes most days and does stretching at home; no formal balance or strength program at the first visit
- S Supports: spouse, adult children, and long-time friends and staff who travel with him
Functional status
- S At the first visit, in the on state about two hours after a levodopa dose: Hoehn and Yahr stage 2.5; MDS-UPDRS Part III 30. Bilateral bradykinesia and rigidity, worse on the right; right-hand rest tremor; reduced facial expression and blinking; soft, monotone speech; reduced arm swing with short steps; recovers unaided on the pull test after three steps. No dyskinesia, wearing-off, or freezing
- S Falls: none in the past year and no near falls; Timed Up and Go 13 seconds without an aid
- S Orthostatic check at the first visit: 130/80 mmHg, pulse 70, after 5 minutes supine; 122/78 mmHg, pulse 76, after 3 minutes standing, without symptoms; no orthostatic hypotension
- S Non-motor screens at the first visit: EAT-10 swallowing screen 2 (below the threshold of 3), no choking or coughing with meals; no dream enactment on the RBD screening questionnaire; Epworth Sleepiness Scale 6; no constipation, urinary urgency, or lightheadedness; no hallucinations; impulse-control screen (QUIP-RS) negative
- S Independent in all activities of daily living; buttoning and handwriting are slow; drives only short local trips in daylight
Mental status
- S Alert and fully oriented; humorous and engaged; speech soft and slow but fluent and coherent; MoCA 27 of 30
- S Mood good; PHQ-9 score 3; no hallucinations or delusions
Allergies and medications
Allergies
- S No known allergy
Medications
- S Carbidopa-levodopa 25/100 mg oral tablet, one tablet by mouth three times daily
- S Carbidopa-levodopa 25/100 mg oral tablet, one and a half tablets by mouth three times daily, 30 minutes before meals
Procedures and immunizations
Procedures
- S Speech therapy: four-week intensive voice treatment (LSVT LOUD), 16 sessions
- S Advance care planning conversation, about 20 minutes
Immunizations
- S 1995-10-14: Influenza vaccine, 1995-1996 season
- S 1996-10-06: Influenza vaccine, 1996-1997 season
- S 1996-10-06: Pneumococcal conjugate vaccine PCV20
- S 1996-10-06: Recombinant zoster vaccine, dose 1 of 2
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
- R 1981: Professional boxing career with repeated blows to the head, ended by retirement in 1981; whether it caused his Parkinson's disease is disputed (CLM-0003, CLM-0006)
- D 1984: Parkinsonian condition diagnosed in 1984, at 42, by a neurologist in New York, with slowness of movement, a masked face, decreased blinking, tremor, and a shuffling gait (CLM-0003, CLM-0004)
Family history
No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| Less slowness of movement after a levodopa adjustment, without dyskinesia or orthostatic hypotension, by the three-month review | 1996-06-09 | completed | MDS-UPDRS Part III fell from 30 to 24; no dyskinesia; no orthostatic hypotension |
| Complete a four-week intensive speech therapy course and keep up daily voice practice | 1996-06-09 | completed | LSVT LOUD course completed; easier to hear in conversation; daily home practice continues |
| No falls through the six-month review, with at least 150 minutes a week of exercise including balance work | 1996-09-08 | completed | No falls; Timed Up and Go improved from 13 to 11 seconds; exercising about 180 minutes a week |
| Name a health care agent and record his goals of care by the preventive visit | 1996-10-06 | completed | Health care agent named and goals of care recorded at the preventive visit |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| Review the levodopa dose and timing at every visit for slowness, wearing-off, and dyskinesia; take doses 30 minutes before meals; check supine and three-minute standing blood pressure after any change; avoid dopamine-blocking drugs such as metoclopramide, prochlorperazine, and most antipsychotics | completed | GL-AAN-PD-2021, GL-AAS-OH-2017, GL-CMID-2026 |
| Movement disorders neurology consultation to confirm the diagnosis against the MDS criteria, adjust levodopa, plan rehabilitation, and advise on genetic testing | completed | GL-MDS-CRIT-2015, GL-AAN-PD-2021, GL-CMID-2026 |
| Four-week intensive speech therapy (LSVT LOUD) for soft speech, and physical therapy for gait, balance, and a home exercise program of at least 150 minutes a week | completed | GL-CMID-2026 |
| Monitor on the CMID schedule: motor examination, Hoehn and Yahr stage, fall check, psychosis and impulse-control questions, and medication review every visit; cognition, mood, sleep, autonomic symptoms, swallowing, speech, and driving yearly; dental examination every six months | completed | GL-CMID-2026, GL-MDS-CRIT-2015 |
| Advance care planning: name a health care agent and record goals of care, and revisit with any change in stage | completed | GL-CMID-2026 |
Planned encounters
- 1996-02-10 — Establishing primary care for Parkinson's disease: motor, non-motor, fall-risk, and orthostatic assessment (ENC-001)
- 1996-03-10 — Four-week follow-up with movement disorders neurology consultation for levodopa adjustment and rehabilitation (ENC-002)
- 1996-06-09 — Three-month Parkinson's disease review after the levodopa increase and speech therapy (ENC-003)
- 1996-09-08 — Six-month Parkinson's disease review (ENC-004)
- 1996-10-06 — Periodic adult preventive visit (ENC-005)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Focused Visit (Follow-up)
- Progress note 04 — Focused Visit (Care-plan review)
- Progress note 05 — Preventive Visit
- Neurology (movement disorders) referral
- Neurology (movement disorders) consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Focused Visit (Follow-up) (XML)
- Progress note 04 — Focused Visit (Care-plan review) (XML)
- Progress note 05 — Preventive Visit (XML)
- Neurology (movement disorders) referral (XML)
- Neurology (movement disorders) consultation (XML)
Sources
| ID | Source | Publisher | Type |
|---|---|---|---|
| SRC-0001 | Muhammad Ali: Explore the Life and Legacy of The Greatest | Louisville Tourism (GoToLouisville.com) | other |
| SRC-0002 | Doctor who diagnosed Muhammad Ali with Parkinson's speaks out | CBS News | other |
| SRC-0003 | Muhammad Ali's long struggle with Parkinson's disease | CBS News (with the Associated Press) | other |
| SRC-0004 | Muhammad Ali Had 'a Mission' to Fight Parkinson's Disease | Barrow Neurological Institute | other |
| SRC-0005 | Ali doctor: 'Muhammad had no regrets about boxing' | Associated Press (via KSL.com) | other |
| SRC-0006 | Death of Muhammad Ali: Boxer died of septic shock | Al Jazeera | other |
| SRC-0007 | Muhammad Ali Dies at 74 | AARP | other |
| SRC-0008 | HISTMED Master Roster v3 | The Human Record project | other |
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review. |
| provenance review | not_started | Recent-death rule: only what Ali's physicians made public, as reported by news outlets and the Barrow Neurological Institute, is used. The boxing link is graded R and disputed. |
| safe messaging review | not_started | Parkinson's disease described with dignity; no behavioral-health diagnosis requiring a safety assessment; death recorded without detail. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.